nodes	percent_of_prediction	percent_of_DWPC	metapath
Lamivudine—Nucleoside Analog—Azathioprine—Crohn's disease	0.708	1	CiPCiCtD
Lamivudine—ABCC4—Mercaptopurine—Crohn's disease	0.0734	0.488	CbGbCtD
Lamivudine—ABCC2—Sulfasalazine—Crohn's disease	0.0356	0.237	CbGbCtD
Lamivudine—ABCG2—Sulfasalazine—Crohn's disease	0.0322	0.214	CbGbCtD
Lamivudine—ABCB1—Prednisone—Crohn's disease	0.00927	0.0617	CbGbCtD
Lamivudine—ABCC2—bile—Crohn's disease	0.00314	0.087	CbGeAlD
Lamivudine—Decitabine—DNMT3A—Crohn's disease	0.00284	1	CrCbGaD
Lamivudine—PGK1—skin of body—Crohn's disease	0.00221	0.0611	CbGeAlD
Lamivudine—NME1—mouth—Crohn's disease	0.00211	0.0585	CbGeAlD
Lamivudine—PCYT2—digestive system—Crohn's disease	0.00205	0.0569	CbGeAlD
Lamivudine—PGK1—digestive system—Crohn's disease	0.00176	0.0488	CbGeAlD
Lamivudine—NT5C—lymphoid tissue—Crohn's disease	0.00151	0.0418	CbGeAlD
Lamivudine—NME1—Carbidopa—Mesalazine—Crohn's disease	0.00147	0.846	CbGdCrCtD
Lamivudine—PCYT1A—digestive system—Crohn's disease	0.0014	0.0387	CbGeAlD
Lamivudine—NME1—skin of body—Crohn's disease	0.00117	0.0324	CbGeAlD
Lamivudine—NME2—epithelium—Crohn's disease	0.00116	0.032	CbGeAlD
Lamivudine—CMPK1—smooth muscle tissue—Crohn's disease	0.00114	0.0316	CbGeAlD
Lamivudine—CMPK1—skin of body—Crohn's disease	0.00113	0.0312	CbGeAlD
Lamivudine—ABCC3—gall bladder—Crohn's disease	0.00109	0.0302	CbGeAlD
Lamivudine—NME1—lymphoid tissue—Crohn's disease	0.000946	0.0262	CbGeAlD
Lamivudine—NME1—digestive system—Crohn's disease	0.000934	0.0259	CbGeAlD
Lamivudine—NME1-NME2—lymph node—Crohn's disease	0.000918	0.0254	CbGeAlD
Lamivudine—CMPK1—lymphoid tissue—Crohn's disease	0.000912	0.0252	CbGeAlD
Lamivudine—CMPK1—digestive system—Crohn's disease	0.000901	0.0249	CbGeAlD
Lamivudine—NME2—lymphoid tissue—Crohn's disease	0.000891	0.0247	CbGeAlD
Lamivudine—NME2—digestive system—Crohn's disease	0.00088	0.0244	CbGeAlD
Lamivudine—NT5C—lymph node—Crohn's disease	0.000851	0.0236	CbGeAlD
Lamivudine—SLC22A3—mouth—Crohn's disease	0.000826	0.0229	CbGeAlD
Lamivudine—SLC22A2—digestive system—Crohn's disease	0.000541	0.015	CbGeAlD
Lamivudine—NME1—lymph node—Crohn's disease	0.000534	0.0148	CbGeAlD
Lamivudine—CMPK1—lymph node—Crohn's disease	0.000514	0.0142	CbGeAlD
Lamivudine—DCK—mammalian vulva—Crohn's disease	0.000511	0.0142	CbGeAlD
Lamivudine—NME2—lymph node—Crohn's disease	0.000503	0.0139	CbGeAlD
Lamivudine—SLC22A3—smooth muscle tissue—Crohn's disease	0.000463	0.0128	CbGeAlD
Lamivudine—DCK—lymphoid tissue—Crohn's disease	0.000454	0.0126	CbGeAlD
Lamivudine—DCK—digestive system—Crohn's disease	0.000448	0.0124	CbGeAlD
Lamivudine—Acne—Mesalazine—Crohn's disease	0.000445	0.00784	CcSEcCtD
Lamivudine—ABCC3—digestive system—Crohn's disease	0.000429	0.0119	CbGeAlD
Lamivudine—Vasodilation—Mesalazine—Crohn's disease	0.000426	0.0075	CcSEcCtD
Lamivudine—Vasodilation procedure—Mesalazine—Crohn's disease	0.000426	0.0075	CcSEcCtD
Lamivudine—Pancreatitis—Mercaptopurine—Crohn's disease	0.000424	0.00747	CcSEcCtD
Lamivudine—Vasculitis—Azathioprine—Crohn's disease	0.000421	0.00742	CcSEcCtD
Lamivudine—SLC22A3—mammalian vulva—Crohn's disease	0.000417	0.0115	CbGeAlD
Lamivudine—Bone disorder—Mesalazine—Crohn's disease	0.000414	0.0073	CcSEcCtD
Lamivudine—Rectal haemorrhage—Mesalazine—Crohn's disease	0.000414	0.0073	CcSEcCtD
Lamivudine—Oropharyngeal pain—Mesalazine—Crohn's disease	0.000412	0.00725	CcSEcCtD
Lamivudine—Pancytopenia—Mercaptopurine—Crohn's disease	0.000411	0.00724	CcSEcCtD
Lamivudine—Aplastic anaemia—Azathioprine—Crohn's disease	0.000386	0.0068	CcSEcCtD
Lamivudine—Musculoskeletal pain—Mesalazine—Crohn's disease	0.000379	0.00667	CcSEcCtD
Lamivudine—Stomatitis—Mercaptopurine—Crohn's disease	0.000376	0.00662	CcSEcCtD
Lamivudine—Eructation—Mesalazine—Crohn's disease	0.000368	0.00648	CcSEcCtD
Lamivudine—Hepatobiliary disease—Mercaptopurine—Crohn's disease	0.000365	0.00643	CcSEcCtD
Lamivudine—ABCC4—digestive system—Crohn's disease	0.000354	0.00981	CbGeAlD
Lamivudine—Aplastic anaemia—Mesalazine—Crohn's disease	0.000351	0.00619	CcSEcCtD
Lamivudine—Neuropathy—Mesalazine—Crohn's disease	0.000351	0.00619	CcSEcCtD
Lamivudine—Hypertriglyceridaemia—Prednisone—Crohn's disease	0.000345	0.00607	CcSEcCtD
Lamivudine—ABCC1—mammalian vulva—Crohn's disease	0.000345	0.00954	CbGeAlD
Lamivudine—ABCC2—digestive system—Crohn's disease	0.000343	0.0095	CbGeAlD
Lamivudine—Mouth ulceration—Mesalazine—Crohn's disease	0.000338	0.00596	CcSEcCtD
Lamivudine—Lymphadenopathy—Mesalazine—Crohn's disease	0.000319	0.00561	CcSEcCtD
Lamivudine—Immune system disorder—Mercaptopurine—Crohn's disease	0.000313	0.00551	CcSEcCtD
Lamivudine—Gastroenteritis—Mesalazine—Crohn's disease	0.000307	0.0054	CcSEcCtD
Lamivudine—Alopecia—Mercaptopurine—Crohn's disease	0.000306	0.00539	CcSEcCtD
Lamivudine—Deafness—Mesalazine—Crohn's disease	0.000304	0.00535	CcSEcCtD
Lamivudine—Blood triglycerides increased—Prednisone—Crohn's disease	0.000302	0.00532	CcSEcCtD
Lamivudine—Malnutrition—Mercaptopurine—Crohn's disease	0.000302	0.00531	CcSEcCtD
Lamivudine—Renal impairment—Mesalazine—Crohn's disease	0.000286	0.00503	CcSEcCtD
Lamivudine—Thirst—Mesalazine—Crohn's disease	0.000286	0.00503	CcSEcCtD
Lamivudine—ABCG2—mammalian vulva—Crohn's disease	0.000285	0.0079	CbGeAlD
Lamivudine—Myopathy—Prednisone—Crohn's disease	0.000282	0.00497	CcSEcCtD
Lamivudine—Hepatomegaly—Prednisone—Crohn's disease	0.00028	0.00493	CcSEcCtD
Lamivudine—Anaemia—Mercaptopurine—Crohn's disease	0.000279	0.00491	CcSEcCtD
Lamivudine—Leukopenia—Mercaptopurine—Crohn's disease	0.00027	0.00475	CcSEcCtD
Lamivudine—Affect lability—Mesalazine—Crohn's disease	0.000267	0.00471	CcSEcCtD
Lamivudine—Migraine—Mesalazine—Crohn's disease	0.000267	0.00471	CcSEcCtD
Lamivudine—Mood swings—Mesalazine—Crohn's disease	0.000257	0.00453	CcSEcCtD
Lamivudine—Arthralgia—Mercaptopurine—Crohn's disease	0.000257	0.00452	CcSEcCtD
Lamivudine—DCK—lymph node—Crohn's disease	0.000256	0.00709	CbGeAlD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.000255	0.00449	CcSEcCtD
Lamivudine—Pancreatitis—Azathioprine—Crohn's disease	0.000253	0.00445	CcSEcCtD
Lamivudine—Liver function test abnormal—Mesalazine—Crohn's disease	0.000251	0.00442	CcSEcCtD
Lamivudine—Abdominal pain upper—Mesalazine—Crohn's disease	0.000248	0.00437	CcSEcCtD
Lamivudine—Abdominal discomfort—Azathioprine—Crohn's disease	0.000247	0.00435	CcSEcCtD
Lamivudine—Oedema—Mercaptopurine—Crohn's disease	0.000246	0.00433	CcSEcCtD
Lamivudine—ABCC3—lymph node—Crohn's disease	0.000245	0.00679	CbGeAlD
Lamivudine—Pancytopenia—Azathioprine—Crohn's disease	0.000245	0.00431	CcSEcCtD
Lamivudine—Aspartate aminotransferase increased—Mesalazine—Crohn's disease	0.000245	0.00431	CcSEcCtD
Lamivudine—Cramp muscle—Mesalazine—Crohn's disease	0.000245	0.00431	CcSEcCtD
Lamivudine—Nasopharyngitis—Mesalazine—Crohn's disease	0.000243	0.00428	CcSEcCtD
Lamivudine—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.000241	0.00424	CcSEcCtD
Lamivudine—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.00024	0.00422	CcSEcCtD
Lamivudine—Skin disorder—Mercaptopurine—Crohn's disease	0.000239	0.00421	CcSEcCtD
Lamivudine—Abdominal distension—Mesalazine—Crohn's disease	0.000236	0.00416	CcSEcCtD
Lamivudine—Acne—Prednisone—Crohn's disease	0.000235	0.00415	CcSEcCtD
Lamivudine—Dysphagia—Mesalazine—Crohn's disease	0.000235	0.00414	CcSEcCtD
Lamivudine—Influenza—Mesalazine—Crohn's disease	0.000235	0.00414	CcSEcCtD
Lamivudine—Anorexia—Mercaptopurine—Crohn's disease	0.000235	0.00413	CcSEcCtD
Lamivudine—Pancreatitis—Mesalazine—Crohn's disease	0.00023	0.00406	CcSEcCtD
Lamivudine—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.000228	0.00401	CcSEcCtD
Lamivudine—Bronchitis—Mesalazine—Crohn's disease	0.000226	0.00398	CcSEcCtD
Lamivudine—Abdominal discomfort—Mesalazine—Crohn's disease	0.000225	0.00397	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.000224	0.00395	CcSEcCtD
Lamivudine—Pancytopenia—Mesalazine—Crohn's disease	0.000223	0.00393	CcSEcCtD
Lamivudine—Dysuria—Mesalazine—Crohn's disease	0.00022	0.00387	CcSEcCtD
Lamivudine—Neutropenia—Mesalazine—Crohn's disease	0.00022	0.00387	CcSEcCtD
Lamivudine—Viral infection—Prednisone—Crohn's disease	0.000219	0.00386	CcSEcCtD
Lamivudine—Hepatobiliary disease—Azathioprine—Crohn's disease	0.000217	0.00383	CcSEcCtD
Lamivudine—Pollakiuria—Mesalazine—Crohn's disease	0.000217	0.00382	CcSEcCtD
Lamivudine—Agranulocytosis—Azathioprine—Crohn's disease	0.000215	0.00378	CcSEcCtD
Lamivudine—Decreased appetite—Mercaptopurine—Crohn's disease	0.000214	0.00377	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.000212	0.00374	CcSEcCtD
Lamivudine—Hypercholesterolaemia—Prednisone—Crohn's disease	0.000209	0.00369	CcSEcCtD
Lamivudine—Depression—Mesalazine—Crohn's disease	0.000209	0.00368	CcSEcCtD
Lamivudine—SLC22A3—lymph node—Crohn's disease	0.000209	0.00578	CbGeAlD
Lamivudine—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.000208	0.00366	CcSEcCtD
Lamivudine—Renal failure—Mesalazine—Crohn's disease	0.000206	0.00363	CcSEcCtD
Lamivudine—Neuropathy peripheral—Mesalazine—Crohn's disease	0.000205	0.00362	CcSEcCtD
Lamivudine—Stomatitis—Mesalazine—Crohn's disease	0.000204	0.0036	CcSEcCtD
Lamivudine—Jaundice—Mesalazine—Crohn's disease	0.000204	0.0036	CcSEcCtD
Lamivudine—Vasculitis—Prednisone—Crohn's disease	0.000203	0.00357	CcSEcCtD
Lamivudine—ABCC4—lymph node—Crohn's disease	0.000202	0.00561	CbGeAlD
Lamivudine—Sweating—Mesalazine—Crohn's disease	0.000201	0.00354	CcSEcCtD
Lamivudine—Hepatobiliary disease—Mesalazine—Crohn's disease	0.000198	0.00349	CcSEcCtD
Lamivudine—Epistaxis—Mesalazine—Crohn's disease	0.000198	0.00348	CcSEcCtD
Lamivudine—Sinusitis—Mesalazine—Crohn's disease	0.000196	0.00346	CcSEcCtD
Lamivudine—ABCC2—lymph node—Crohn's disease	0.000196	0.00543	CbGeAlD
Lamivudine—Agranulocytosis—Mesalazine—Crohn's disease	0.000195	0.00344	CcSEcCtD
Lamivudine—Erythema multiforme—Azathioprine—Crohn's disease	0.000195	0.00344	CcSEcCtD
Lamivudine—Body temperature increased—Mercaptopurine—Crohn's disease	0.000195	0.00343	CcSEcCtD
Lamivudine—Rhinitis—Mesalazine—Crohn's disease	0.000188	0.00332	CcSEcCtD
Lamivudine—Hepatitis—Mesalazine—Crohn's disease	0.000188	0.00331	CcSEcCtD
Lamivudine—Pharyngitis—Mesalazine—Crohn's disease	0.000187	0.00329	CcSEcCtD
Lamivudine—Immune system disorder—Azathioprine—Crohn's disease	0.000186	0.00328	CcSEcCtD
Lamivudine—Mediastinal disorder—Azathioprine—Crohn's disease	0.000186	0.00328	CcSEcCtD
Lamivudine—Neuropathy—Prednisone—Crohn's disease	0.000186	0.00328	CcSEcCtD
Lamivudine—Chills—Azathioprine—Crohn's disease	0.000185	0.00326	CcSEcCtD
Lamivudine—Connective tissue disorder—Mesalazine—Crohn's disease	0.000185	0.00325	CcSEcCtD
Lamivudine—Alopecia—Azathioprine—Crohn's disease	0.000182	0.00321	CcSEcCtD
Lamivudine—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000181	0.00319	CcSEcCtD
Lamivudine—Erythema multiforme—Mesalazine—Crohn's disease	0.000178	0.00313	CcSEcCtD
Lamivudine—ABCC1—lymph node—Crohn's disease	0.000173	0.00478	CbGeAlD
Lamivudine—Sepsis—Prednisone—Crohn's disease	0.000172	0.00303	CcSEcCtD
Lamivudine—Immune system disorder—Mesalazine—Crohn's disease	0.00017	0.00299	CcSEcCtD
Lamivudine—Mediastinal disorder—Mesalazine—Crohn's disease	0.000169	0.00298	CcSEcCtD
Lamivudine—Chills—Mesalazine—Crohn's disease	0.000169	0.00297	CcSEcCtD
Lamivudine—Diarrhoea—Mercaptopurine—Crohn's disease	0.000168	0.00297	CcSEcCtD
Lamivudine—Ill-defined disorder—Azathioprine—Crohn's disease	0.000167	0.00294	CcSEcCtD
Lamivudine—Alopecia—Mesalazine—Crohn's disease	0.000166	0.00293	CcSEcCtD
Lamivudine—Anaemia—Azathioprine—Crohn's disease	0.000166	0.00292	CcSEcCtD
Lamivudine—Erythema—Mesalazine—Crohn's disease	0.000164	0.00288	CcSEcCtD
Lamivudine—ABCB1—epithelium—Crohn's disease	0.000162	0.00449	CbGeAlD
Lamivudine—Malaise—Azathioprine—Crohn's disease	0.000162	0.00285	CcSEcCtD
Lamivudine—Flatulence—Mesalazine—Crohn's disease	0.000161	0.00284	CcSEcCtD
Lamivudine—Leukopenia—Azathioprine—Crohn's disease	0.000161	0.00283	CcSEcCtD
Lamivudine—Tension—Mesalazine—Crohn's disease	0.000161	0.00283	CcSEcCtD
Lamivudine—Dysgeusia—Mesalazine—Crohn's disease	0.00016	0.00282	CcSEcCtD
Lamivudine—Nervousness—Mesalazine—Crohn's disease	0.000159	0.0028	CcSEcCtD
Lamivudine—Back pain—Mesalazine—Crohn's disease	0.000158	0.00279	CcSEcCtD
Lamivudine—Muscle spasms—Mesalazine—Crohn's disease	0.000157	0.00277	CcSEcCtD
Lamivudine—Vomiting—Mercaptopurine—Crohn's disease	0.000156	0.00276	CcSEcCtD
Lamivudine—Injury—Prednisone—Crohn's disease	0.000156	0.00275	CcSEcCtD
Lamivudine—Rash—Mercaptopurine—Crohn's disease	0.000155	0.00273	CcSEcCtD
Lamivudine—Dermatitis—Mercaptopurine—Crohn's disease	0.000155	0.00273	CcSEcCtD
Lamivudine—Tremor—Mesalazine—Crohn's disease	0.000153	0.0027	CcSEcCtD
Lamivudine—Myalgia—Azathioprine—Crohn's disease	0.000153	0.00269	CcSEcCtD
Lamivudine—Arthralgia—Azathioprine—Crohn's disease	0.000153	0.00269	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.000152	0.00268	CcSEcCtD
Lamivudine—Ill-defined disorder—Mesalazine—Crohn's disease	0.000152	0.00267	CcSEcCtD
Lamivudine—Anaemia—Mesalazine—Crohn's disease	0.000151	0.00266	CcSEcCtD
Lamivudine—Discomfort—Azathioprine—Crohn's disease	0.000151	0.00266	CcSEcCtD
Lamivudine—Angioedema—Mesalazine—Crohn's disease	0.00015	0.00263	CcSEcCtD
Lamivudine—Malaise—Mesalazine—Crohn's disease	0.000148	0.0026	CcSEcCtD
Lamivudine—Vertigo—Mesalazine—Crohn's disease	0.000147	0.00259	CcSEcCtD
Lamivudine—Syncope—Mesalazine—Crohn's disease	0.000147	0.00258	CcSEcCtD
Lamivudine—Leukopenia—Mesalazine—Crohn's disease	0.000146	0.00258	CcSEcCtD
Lamivudine—Nausea—Mercaptopurine—Crohn's disease	0.000146	0.00257	CcSEcCtD
Lamivudine—Infection—Azathioprine—Crohn's disease	0.000146	0.00257	CcSEcCtD
Lamivudine—Loss of consciousness—Mesalazine—Crohn's disease	0.000144	0.00253	CcSEcCtD
Lamivudine—Thrombocytopenia—Azathioprine—Crohn's disease	0.000144	0.00253	CcSEcCtD
Lamivudine—ABCG2—lymph node—Crohn's disease	0.000143	0.00396	CbGeAlD
Lamivudine—Cough—Mesalazine—Crohn's disease	0.000143	0.00252	CcSEcCtD
Lamivudine—Skin disorder—Azathioprine—Crohn's disease	0.000142	0.00251	CcSEcCtD
Lamivudine—Affect lability—Prednisone—Crohn's disease	0.000142	0.00249	CcSEcCtD
Lamivudine—ABCB1—mammalian vulva—Crohn's disease	0.000141	0.0039	CbGeAlD
Lamivudine—Arthralgia—Mesalazine—Crohn's disease	0.000139	0.00245	CcSEcCtD
Lamivudine—Chest pain—Mesalazine—Crohn's disease	0.000139	0.00245	CcSEcCtD
Lamivudine—Myalgia—Mesalazine—Crohn's disease	0.000139	0.00245	CcSEcCtD
Lamivudine—Anxiety—Mesalazine—Crohn's disease	0.000139	0.00245	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.000138	0.00244	CcSEcCtD
Lamivudine—Discomfort—Mesalazine—Crohn's disease	0.000138	0.00242	CcSEcCtD
Lamivudine—Hypotension—Azathioprine—Crohn's disease	0.000137	0.00241	CcSEcCtD
Lamivudine—Dry mouth—Mesalazine—Crohn's disease	0.000136	0.0024	CcSEcCtD
Lamivudine—Mood swings—Prednisone—Crohn's disease	0.000136	0.0024	CcSEcCtD
Lamivudine—DCK—Desoximetasone—Prednisone—Crohn's disease	0.000135	0.078	CbGdCrCtD
Lamivudine—Confusional state—Mesalazine—Crohn's disease	0.000135	0.00237	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000134	0.00235	CcSEcCtD
Lamivudine—Anaphylactic shock—Mesalazine—Crohn's disease	0.000134	0.00235	CcSEcCtD
Lamivudine—Oedema—Mesalazine—Crohn's disease	0.000134	0.00235	CcSEcCtD
Lamivudine—Infection—Mesalazine—Crohn's disease	0.000133	0.00234	CcSEcCtD
Lamivudine—Shock—Mesalazine—Crohn's disease	0.000131	0.00231	CcSEcCtD
Lamivudine—DCK—Diflorasone—Prednisone—Crohn's disease	0.000131	0.0757	CbGdCrCtD
Lamivudine—Nervous system disorder—Mesalazine—Crohn's disease	0.000131	0.00231	CcSEcCtD
Lamivudine—Thrombocytopenia—Mesalazine—Crohn's disease	0.000131	0.0023	CcSEcCtD
Lamivudine—Skin disorder—Mesalazine—Crohn's disease	0.00013	0.00228	CcSEcCtD
Lamivudine—Hyperhidrosis—Mesalazine—Crohn's disease	0.000129	0.00227	CcSEcCtD
Lamivudine—Anorexia—Mesalazine—Crohn's disease	0.000127	0.00224	CcSEcCtD
Lamivudine—Muscular weakness—Prednisone—Crohn's disease	0.000127	0.00223	CcSEcCtD
Lamivudine—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.000127	0.00223	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000127	0.00223	CcSEcCtD
Lamivudine—Abdominal distension—Prednisone—Crohn's disease	0.000125	0.0022	CcSEcCtD
Lamivudine—ABCB1—lymphoid tissue—Crohn's disease	0.000125	0.00346	CbGeAlD
Lamivudine—Hypotension—Mesalazine—Crohn's disease	0.000125	0.0022	CcSEcCtD
Lamivudine—ABCB1—digestive system—Crohn's disease	0.000123	0.00342	CbGeAlD
Lamivudine—Pancreatitis—Prednisone—Crohn's disease	0.000122	0.00215	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000122	0.00214	CcSEcCtD
Lamivudine—Sweating increased—Prednisone—Crohn's disease	0.000121	0.00213	CcSEcCtD
Lamivudine—Feeling abnormal—Azathioprine—Crohn's disease	0.000121	0.00213	CcSEcCtD
Lamivudine—Insomnia—Mesalazine—Crohn's disease	0.000121	0.00213	CcSEcCtD
Lamivudine—Paraesthesia—Mesalazine—Crohn's disease	0.00012	0.00211	CcSEcCtD
Lamivudine—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00012	0.00211	CcSEcCtD
Lamivudine—ABCC3—Bile acid and bile salt metabolism—ALB—Crohn's disease	0.00012	0.00271	CbGpPWpGaD
Lamivudine—SLC22A3—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000119	0.0027	CbGpPWpGaD
Lamivudine—SLC22A3—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000119	0.0027	CbGpPWpGaD
Lamivudine—Dyspnoea—Mesalazine—Crohn's disease	0.000119	0.0021	CcSEcCtD
Lamivudine—Somnolence—Mesalazine—Crohn's disease	0.000119	0.00209	CcSEcCtD
Lamivudine—PGK1—Disease—SEL1L—Crohn's disease	0.000118	0.00268	CbGpPWpGaD
Lamivudine—Dyspepsia—Mesalazine—Crohn's disease	0.000118	0.00207	CcSEcCtD
Lamivudine—Neutropenia—Prednisone—Crohn's disease	0.000116	0.00205	CcSEcCtD
Lamivudine—Decreased appetite—Mesalazine—Crohn's disease	0.000116	0.00204	CcSEcCtD
Lamivudine—Body temperature increased—Azathioprine—Crohn's disease	0.000116	0.00204	CcSEcCtD
Lamivudine—Abdominal pain—Azathioprine—Crohn's disease	0.000116	0.00204	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000115	0.00203	CcSEcCtD
Lamivudine—Fatigue—Mesalazine—Crohn's disease	0.000115	0.00203	CcSEcCtD
Lamivudine—Constipation—Mesalazine—Crohn's disease	0.000114	0.00201	CcSEcCtD
Lamivudine—Pain—Mesalazine—Crohn's disease	0.000114	0.00201	CcSEcCtD
Lamivudine—Hyperglycaemia—Prednisone—Crohn's disease	0.000112	0.00197	CcSEcCtD
Lamivudine—PCYT1A—Metabolism—PLA2G4F—Crohn's disease	0.000111	0.00252	CbGpPWpGaD
Lamivudine—Depression—Prednisone—Crohn's disease	0.00011	0.00195	CcSEcCtD
Lamivudine—Feeling abnormal—Mesalazine—Crohn's disease	0.00011	0.00194	CcSEcCtD
Lamivudine—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000109	0.00192	CcSEcCtD
Lamivudine—Neuropathy peripheral—Prednisone—Crohn's disease	0.000109	0.00191	CcSEcCtD
Lamivudine—Hypersensitivity—Azathioprine—Crohn's disease	0.000108	0.0019	CcSEcCtD
Lamivudine—PGK1—Disease—LTF—Crohn's disease	0.000106	0.0024	CbGpPWpGaD
Lamivudine—Urticaria—Mesalazine—Crohn's disease	0.000106	0.00187	CcSEcCtD
Lamivudine—Abdominal pain—Mesalazine—Crohn's disease	0.000106	0.00186	CcSEcCtD
Lamivudine—Body temperature increased—Mesalazine—Crohn's disease	0.000106	0.00186	CcSEcCtD
Lamivudine—ABCB1—Allograft Rejection—LRRK2—Crohn's disease	0.000103	0.00234	CbGpPWpGaD
Lamivudine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.000102	0.00232	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—MTMR3—Crohn's disease	0.000102	0.0023	CbGpPWpGaD
Lamivudine—NME2—Metabolism—PLA2G4F—Crohn's disease	0.000102	0.0023	CbGpPWpGaD
Lamivudine—Diarrhoea—Azathioprine—Crohn's disease	0.0001	0.00177	CcSEcCtD
Lamivudine—Hypersensitivity—Mesalazine—Crohn's disease	9.84e-05	0.00173	CcSEcCtD
Lamivudine—Connective tissue disorder—Prednisone—Crohn's disease	9.77e-05	0.00172	CcSEcCtD
Lamivudine—PCYT2—Metabolism—FADS1—Crohn's disease	9.72e-05	0.0022	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—FADS1—Crohn's disease	9.72e-05	0.0022	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—FADS1—Crohn's disease	9.72e-05	0.0022	CbGpPWpGaD
Lamivudine—Dizziness—Azathioprine—Crohn's disease	9.7e-05	0.00171	CcSEcCtD
Lamivudine—Asthenia—Mesalazine—Crohn's disease	9.58e-05	0.00169	CcSEcCtD
Lamivudine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	9.55e-05	0.00216	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—MTMR3—Crohn's disease	9.45e-05	0.00214	CbGpPWpGaD
Lamivudine—Pruritus—Mesalazine—Crohn's disease	9.45e-05	0.00166	CcSEcCtD
Lamivudine—Vomiting—Azathioprine—Crohn's disease	9.32e-05	0.00164	CcSEcCtD
Lamivudine—Rash—Azathioprine—Crohn's disease	9.25e-05	0.00163	CcSEcCtD
Lamivudine—Dermatitis—Azathioprine—Crohn's disease	9.24e-05	0.00163	CcSEcCtD
Lamivudine—Headache—Azathioprine—Crohn's disease	9.19e-05	0.00162	CcSEcCtD
Lamivudine—Diarrhoea—Mesalazine—Crohn's disease	9.14e-05	0.00161	CcSEcCtD
Lamivudine—PCYT2—Metabolism—GPX4—Crohn's disease	9.1e-05	0.00206	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—GPX4—Crohn's disease	9.1e-05	0.00206	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—GPX4—Crohn's disease	9.1e-05	0.00206	CbGpPWpGaD
Lamivudine—Immune system disorder—Prednisone—Crohn's disease	8.98e-05	0.00158	CcSEcCtD
Lamivudine—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	8.97e-05	0.00203	CbGpPWpGaD
Lamivudine—SLC22A6—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	8.97e-05	0.00203	CbGpPWpGaD
Lamivudine—Dizziness—Mesalazine—Crohn's disease	8.83e-05	0.00156	CcSEcCtD
Lamivudine—Alopecia—Prednisone—Crohn's disease	8.79e-05	0.00155	CcSEcCtD
Lamivudine—CMPK1—Metabolism—GCKR—Crohn's disease	8.79e-05	0.00199	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—GCKR—Crohn's disease	8.79e-05	0.00199	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—GCKR—Crohn's disease	8.79e-05	0.00199	CbGpPWpGaD
Lamivudine—Nausea—Azathioprine—Crohn's disease	8.71e-05	0.00153	CcSEcCtD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—F5—Crohn's disease	8.67e-05	0.00196	CbGpPWpGaD
Lamivudine—Erythema—Prednisone—Crohn's disease	8.66e-05	0.00152	CcSEcCtD
Lamivudine—Malnutrition—Prednisone—Crohn's disease	8.66e-05	0.00152	CcSEcCtD
Lamivudine—NME2—Metabolism—MTMR3—Crohn's disease	8.65e-05	0.00196	CbGpPWpGaD
Lamivudine—PGK1—Disease—GCKR—Crohn's disease	8.55e-05	0.00194	CbGpPWpGaD
Lamivudine—Vomiting—Mesalazine—Crohn's disease	8.49e-05	0.0015	CcSEcCtD
Lamivudine—Rash—Mesalazine—Crohn's disease	8.42e-05	0.00148	CcSEcCtD
Lamivudine—Dermatitis—Mesalazine—Crohn's disease	8.41e-05	0.00148	CcSEcCtD
Lamivudine—SLC22A3—SLC-mediated transmembrane transport—GCKR—Crohn's disease	8.4e-05	0.0019	CbGpPWpGaD
Lamivudine—Headache—Mesalazine—Crohn's disease	8.37e-05	0.00147	CcSEcCtD
Lamivudine—Ill-defined disorder—Prednisone—Crohn's disease	8.03e-05	0.00141	CcSEcCtD
Lamivudine—Anaemia—Prednisone—Crohn's disease	8e-05	0.00141	CcSEcCtD
Lamivudine—Nausea—Mesalazine—Crohn's disease	7.93e-05	0.0014	CcSEcCtD
Lamivudine—PGK1—Metabolism—FADS1—Crohn's disease	7.92e-05	0.00179	CbGpPWpGaD
Lamivudine—Angioedema—Prednisone—Crohn's disease	7.91e-05	0.00139	CcSEcCtD
Lamivudine—Malaise—Prednisone—Crohn's disease	7.81e-05	0.00138	CcSEcCtD
Lamivudine—Vertigo—Prednisone—Crohn's disease	7.78e-05	0.00137	CcSEcCtD
Lamivudine—Syncope—Prednisone—Crohn's disease	7.77e-05	0.00137	CcSEcCtD
Lamivudine—NME1—Metabolism—PLA2G4F—Crohn's disease	7.71e-05	0.00174	CbGpPWpGaD
Lamivudine—Loss of consciousness—Prednisone—Crohn's disease	7.61e-05	0.00134	CcSEcCtD
Lamivudine—ABCG2—HIF-1-alpha transcription factor network—SMAD3—Crohn's disease	7.58e-05	0.00172	CbGpPWpGaD
Lamivudine—PGK1—Disease—SLC11A1—Crohn's disease	7.56e-05	0.00171	CbGpPWpGaD
Lamivudine—Convulsion—Prednisone—Crohn's disease	7.5e-05	0.00132	CcSEcCtD
Lamivudine—SLC22A2—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	7.48e-05	0.00169	CbGpPWpGaD
Lamivudine—SLC22A2—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	7.48e-05	0.00169	CbGpPWpGaD
Lamivudine—SLC22A3—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	7.43e-05	0.00168	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—GPX4—Crohn's disease	7.42e-05	0.00168	CbGpPWpGaD
Lamivudine—Myalgia—Prednisone—Crohn's disease	7.37e-05	0.0013	CcSEcCtD
Lamivudine—Arthralgia—Prednisone—Crohn's disease	7.37e-05	0.0013	CcSEcCtD
Lamivudine—PCYT1A—Metabolism—FADS1—Crohn's disease	7.36e-05	0.00167	CbGpPWpGaD
Lamivudine—Anxiety—Prednisone—Crohn's disease	7.35e-05	0.00129	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	7.32e-05	0.00129	CcSEcCtD
Lamivudine—Discomfort—Prednisone—Crohn's disease	7.28e-05	0.00128	CcSEcCtD
Lamivudine—PGK1—Metabolism—GCKR—Crohn's disease	7.16e-05	0.00162	CbGpPWpGaD
Lamivudine—Anaphylactic shock—Prednisone—Crohn's disease	7.07e-05	0.00124	CcSEcCtD
Lamivudine—Oedema—Prednisone—Crohn's disease	7.07e-05	0.00124	CcSEcCtD
Lamivudine—ABCB1—lymph node—Crohn's disease	7.05e-05	0.00195	CbGeAlD
Lamivudine—Infection—Prednisone—Crohn's disease	7.02e-05	0.00124	CcSEcCtD
Lamivudine—SLC22A1—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	6.97e-05	0.00158	CbGpPWpGaD
Lamivudine—SLC22A1—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	6.97e-05	0.00158	CbGpPWpGaD
Lamivudine—Shock—Prednisone—Crohn's disease	6.95e-05	0.00122	CcSEcCtD
Lamivudine—Nervous system disorder—Prednisone—Crohn's disease	6.93e-05	0.00122	CcSEcCtD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	6.91e-05	0.00157	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—GPX4—Crohn's disease	6.9e-05	0.00156	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	6.89e-05	0.00156	CbGpPWpGaD
Lamivudine—Skin disorder—Prednisone—Crohn's disease	6.86e-05	0.00121	CcSEcCtD
Lamivudine—Hyperhidrosis—Prednisone—Crohn's disease	6.83e-05	0.0012	CcSEcCtD
Lamivudine—Anorexia—Prednisone—Crohn's disease	6.74e-05	0.00119	CcSEcCtD
Lamivudine—NME2—Metabolism—FADS1—Crohn's disease	6.74e-05	0.00153	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—GCKR—Crohn's disease	6.66e-05	0.00151	CbGpPWpGaD
Lamivudine—NME1—Metabolism—MTMR3—Crohn's disease	6.55e-05	0.00148	CbGpPWpGaD
Lamivudine—PGK1—Disease—RBX1—Crohn's disease	6.48e-05	0.00147	CbGpPWpGaD
Lamivudine—PGK1—Disease—HSPA1B—Crohn's disease	6.48e-05	0.00147	CbGpPWpGaD
Lamivudine—Musculoskeletal discomfort—Prednisone—Crohn's disease	6.44e-05	0.00113	CcSEcCtD
Lamivudine—Insomnia—Prednisone—Crohn's disease	6.39e-05	0.00113	CcSEcCtD
Lamivudine—Paraesthesia—Prednisone—Crohn's disease	6.35e-05	0.00112	CcSEcCtD
Lamivudine—SLC22A6—SLC-mediated transmembrane transport—GCKR—Crohn's disease	6.32e-05	0.00143	CbGpPWpGaD
Lamivudine—NME2—Metabolism—GPX4—Crohn's disease	6.31e-05	0.00143	CbGpPWpGaD
Lamivudine—ABCC1—Arachidonic acid metabolism—PTGS2—Crohn's disease	6.3e-05	0.00143	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	6.28e-05	0.00142	CbGpPWpGaD
Lamivudine—Dyspepsia—Prednisone—Crohn's disease	6.22e-05	0.0011	CcSEcCtD
Lamivudine—Decreased appetite—Prednisone—Crohn's disease	6.14e-05	0.00108	CcSEcCtD
Lamivudine—Fatigue—Prednisone—Crohn's disease	6.09e-05	0.00107	CcSEcCtD
Lamivudine—NME2—Metabolism—GCKR—Crohn's disease	6.09e-05	0.00138	CbGpPWpGaD
Lamivudine—SLC22A3—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	6.06e-05	0.00137	CbGpPWpGaD
Lamivudine—SLC22A3—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	6.06e-05	0.00137	CbGpPWpGaD
Lamivudine—Constipation—Prednisone—Crohn's disease	6.04e-05	0.00106	CcSEcCtD
Lamivudine—ABCC4—Platelet degranulation—ALB—Crohn's disease	5.93e-05	0.00134	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	5.86e-05	0.00133	CbGpPWpGaD
Lamivudine—Feeling abnormal—Prednisone—Crohn's disease	5.82e-05	0.00103	CcSEcCtD
Lamivudine—Gastrointestinal pain—Prednisone—Crohn's disease	5.78e-05	0.00102	CcSEcCtD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	5.72e-05	0.00129	CbGpPWpGaD
Lamivudine—PGK1—Disease—UBE2D1—Crohn's disease	5.68e-05	0.00129	CbGpPWpGaD
Lamivudine—ABCC4—Response to elevated platelet cytosolic Ca2+—ALB—Crohn's disease	5.65e-05	0.00128	CbGpPWpGaD
Lamivudine—Urticaria—Prednisone—Crohn's disease	5.61e-05	0.000989	CcSEcCtD
Lamivudine—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	5.59e-05	0.00127	CbGpPWpGaD
Lamivudine—Abdominal pain—Prednisone—Crohn's disease	5.59e-05	0.000984	CcSEcCtD
Lamivudine—Body temperature increased—Prednisone—Crohn's disease	5.59e-05	0.000984	CcSEcCtD
Lamivudine—ABCC3—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	5.57e-05	0.00126	CbGpPWpGaD
Lamivudine—ABCC3—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	5.57e-05	0.00126	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	5.49e-05	0.00124	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—IL17A—Crohn's disease	5.42e-05	0.00123	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	5.4e-05	0.00122	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PLA2G4F—Crohn's disease	5.29e-05	0.0012	CbGpPWpGaD
Lamivudine—SLC22A2—SLC-mediated transmembrane transport—GCKR—Crohn's disease	5.27e-05	0.00119	CbGpPWpGaD
Lamivudine—ABCC4—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	5.24e-05	0.00119	CbGpPWpGaD
Lamivudine—ABCC4—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	5.24e-05	0.00119	CbGpPWpGaD
Lamivudine—Hypersensitivity—Prednisone—Crohn's disease	5.21e-05	0.000917	CcSEcCtD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—IL3—Crohn's disease	5.2e-05	0.00118	CbGpPWpGaD
Lamivudine—NME1—Metabolism—FADS1—Crohn's disease	5.1e-05	0.00116	CbGpPWpGaD
Lamivudine—Asthenia—Prednisone—Crohn's disease	5.07e-05	0.000893	CcSEcCtD
Lamivudine—ABCB1—Allograft Rejection—IL12B—Crohn's disease	5.04e-05	0.00114	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—RASGRP1—Crohn's disease	5.03e-05	0.00114	CbGpPWpGaD
Lamivudine—Pruritus—Prednisone—Crohn's disease	5e-05	0.000881	CcSEcCtD
Lamivudine—SLC22A1—SLC-mediated transmembrane transport—GCKR—Crohn's disease	4.91e-05	0.00111	CbGpPWpGaD
Lamivudine—Diarrhoea—Prednisone—Crohn's disease	4.84e-05	0.000852	CcSEcCtD
Lamivudine—NME1—Metabolism—GPX4—Crohn's disease	4.78e-05	0.00108	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	4.76e-05	0.00108	CbGpPWpGaD
Lamivudine—Dizziness—Prednisone—Crohn's disease	4.67e-05	0.000823	CcSEcCtD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	4.67e-05	0.00106	CbGpPWpGaD
Lamivudine—SLC22A2—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	4.66e-05	0.00105	CbGpPWpGaD
Lamivudine—NME1—Metabolism—GCKR—Crohn's disease	4.62e-05	0.00105	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	4.59e-05	0.00104	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	4.56e-05	0.00103	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	4.56e-05	0.00103	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	4.56e-05	0.00103	CbGpPWpGaD
Lamivudine—DCK—Metabolism—MTMR3—Crohn's disease	4.49e-05	0.00102	CbGpPWpGaD
Lamivudine—Vomiting—Prednisone—Crohn's disease	4.49e-05	0.000791	CcSEcCtD
Lamivudine—ABCC4—Hemostasis—F5—Crohn's disease	4.47e-05	0.00101	CbGpPWpGaD
Lamivudine—Rash—Prednisone—Crohn's disease	4.46e-05	0.000785	CcSEcCtD
Lamivudine—Dermatitis—Prednisone—Crohn's disease	4.45e-05	0.000784	CcSEcCtD
Lamivudine—Headache—Prednisone—Crohn's disease	4.43e-05	0.00078	CcSEcCtD
Lamivudine—ABCC2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	4.42e-05	0.001	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	4.42e-05	0.001	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	4.36e-05	0.000988	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	4.36e-05	0.000988	CbGpPWpGaD
Lamivudine—SLC22A1—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	4.34e-05	0.000983	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	4.27e-05	0.000968	CbGpPWpGaD
Lamivudine—SLC22A3—Transmembrane transport of small molecules—GCKR—Crohn's disease	4.27e-05	0.000967	CbGpPWpGaD
Lamivudine—Nausea—Prednisone—Crohn's disease	4.2e-05	0.000739	CcSEcCtD
Lamivudine—PCYT1A—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	4.16e-05	0.000943	CbGpPWpGaD
Lamivudine—ABCB1—HIF-1-alpha transcription factor network—SMAD3—Crohn's disease	4.1e-05	0.000928	CbGpPWpGaD
Lamivudine—PGK1—Disease—SMAD3—Crohn's disease	4.07e-05	0.000921	CbGpPWpGaD
Lamivudine—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—Crohn's disease	4.04e-05	0.000916	CbGpPWpGaD
Lamivudine—ABCC3—Transmembrane transport of small molecules—GCKR—Crohn's disease	3.92e-05	0.000889	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	3.84e-05	0.000869	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	3.84e-05	0.000869	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	3.8e-05	0.000861	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	3.8e-05	0.000861	CbGpPWpGaD
Lamivudine—SLC22A3—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	3.77e-05	0.000854	CbGpPWpGaD
Lamivudine—ABCC4—Transmembrane transport of small molecules—GCKR—Crohn's disease	3.69e-05	0.000835	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—IL10—Crohn's disease	3.69e-05	0.000835	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—IL2RA—Crohn's disease	3.64e-05	0.000824	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	3.58e-05	0.00081	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	3.54e-05	0.000802	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	3.54e-05	0.000802	CbGpPWpGaD
Lamivudine—DCK—Metabolism—FADS1—Crohn's disease	3.5e-05	0.000793	CbGpPWpGaD
Lamivudine—ABCC3—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	3.47e-05	0.000785	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	3.35e-05	0.000758	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PLA2G4F—Crohn's disease	3.34e-05	0.000756	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—IL2RA—Crohn's disease	3.29e-05	0.000744	CbGpPWpGaD
Lamivudine—DCK—Metabolism—GPX4—Crohn's disease	3.28e-05	0.000742	CbGpPWpGaD
Lamivudine—ABCC4—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	3.26e-05	0.000738	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—GCKR—Crohn's disease	3.21e-05	0.000727	CbGpPWpGaD
Lamivudine—DCK—Metabolism—GCKR—Crohn's disease	3.17e-05	0.000717	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—GCKR—Crohn's disease	3.11e-05	0.000704	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—GCKR—Crohn's disease	3.07e-05	0.000696	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PLA2G4F—Crohn's disease	3.07e-05	0.000695	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	2.84e-05	0.000643	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—MTMR3—Crohn's disease	2.84e-05	0.000643	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—ALB—Crohn's disease	2.8e-05	0.000633	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—ALB—Crohn's disease	2.8e-05	0.000633	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—ALB—Crohn's disease	2.8e-05	0.000633	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	2.75e-05	0.000623	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—ITGA4—Crohn's disease	2.75e-05	0.000622	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	2.72e-05	0.000615	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—GCKR—Crohn's disease	2.71e-05	0.000613	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—IL3—Crohn's disease	2.68e-05	0.000606	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—GCKR—Crohn's disease	2.68e-05	0.000606	CbGpPWpGaD
Lamivudine—SLC22A3—SLC-mediated transmembrane transport—ALB—Crohn's disease	2.67e-05	0.000605	CbGpPWpGaD
Lamivudine—PGK1—Disease—TYK2—Crohn's disease	2.65e-05	0.000601	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—ALB—Crohn's disease	2.63e-05	0.000596	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—MTMR3—Crohn's disease	2.61e-05	0.000591	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—RASGRP1—Crohn's disease	2.59e-05	0.000587	CbGpPWpGaD
Lamivudine—PGK1—Disease—JAK2—Crohn's disease	2.53e-05	0.000573	CbGpPWpGaD
Lamivudine—ABCC1—Disease—RSPO3—Crohn's disease	2.51e-05	0.000568	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—GCKR—Crohn's disease	2.5e-05	0.000565	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—PTGS2—Crohn's disease	2.45e-05	0.000554	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—PTGS2—Crohn's disease	2.45e-05	0.000554	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—PTGS2—Crohn's disease	2.45e-05	0.000554	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—JAK2—Crohn's disease	2.45e-05	0.000554	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PLA2G4F—Crohn's disease	2.4e-05	0.000544	CbGpPWpGaD
Lamivudine—PGK1—Disease—CD4—Crohn's disease	2.4e-05	0.000543	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	2.39e-05	0.000542	CbGpPWpGaD
Lamivudine—PGK1—Disease—PTGS2—Crohn's disease	2.38e-05	0.000539	CbGpPWpGaD
Lamivudine—ABCC1—Disease—SEL1L—Crohn's disease	2.38e-05	0.000539	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	2.37e-05	0.000536	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	2.31e-05	0.000524	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—ALB—Crohn's disease	2.28e-05	0.000516	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—FADS1—Crohn's disease	2.21e-05	0.000501	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	2.21e-05	0.0005	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—IFNG—Crohn's disease	2.17e-05	0.000491	CbGpPWpGaD
Lamivudine—ABCC1—Disease—LTF—Crohn's disease	2.13e-05	0.000483	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—ALB—Crohn's disease	2.12e-05	0.00048	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PLA2G4F—Crohn's disease	2.12e-05	0.000479	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PLA2G4F—Crohn's disease	2.09e-05	0.000474	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	2.08e-05	0.00047	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	2.08e-05	0.00047	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—GPX4—Crohn's disease	2.07e-05	0.000469	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—MTMR3—Crohn's disease	2.04e-05	0.000463	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—FADS1—Crohn's disease	2.03e-05	0.00046	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—CXCL8—Crohn's disease	2.02e-05	0.000456	CbGpPWpGaD
Lamivudine—SLC22A6—SLC-mediated transmembrane transport—ALB—Crohn's disease	2.01e-05	0.000455	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—GCKR—Crohn's disease	2e-05	0.000453	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—PTGS2—Crohn's disease	1.99e-05	0.000452	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PLA2G4F—Crohn's disease	1.95e-05	0.000442	CbGpPWpGaD
Lamivudine—NME2—Metabolism—ALB—Crohn's disease	1.94e-05	0.000439	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—IL1B—Crohn's disease	1.93e-05	0.000438	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—GPX4—Crohn's disease	1.9e-05	0.000431	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—IL2RA—Crohn's disease	1.88e-05	0.000425	CbGpPWpGaD
Lamivudine—PGK1—Disease—STAT3—Crohn's disease	1.86e-05	0.000421	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—PTGS2—Crohn's disease	1.85e-05	0.00042	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—GCKR—Crohn's disease	1.84e-05	0.000416	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—MTMR3—Crohn's disease	1.8e-05	0.000407	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—MTMR3—Crohn's disease	1.78e-05	0.000403	CbGpPWpGaD
Lamivudine—ABCC1—Disease—GCKR—Crohn's disease	1.72e-05	0.000389	CbGpPWpGaD
Lamivudine—NME2—Metabolism—PTGS2—Crohn's disease	1.7e-05	0.000384	CbGpPWpGaD
Lamivudine—SLC22A2—SLC-mediated transmembrane transport—ALB—Crohn's disease	1.68e-05	0.00038	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—MTMR3—Crohn's disease	1.66e-05	0.000376	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—FADS1—Crohn's disease	1.59e-05	0.000361	CbGpPWpGaD
Lamivudine—SLC22A1—SLC-mediated transmembrane transport—ALB—Crohn's disease	1.56e-05	0.000354	CbGpPWpGaD
Lamivudine—ABCC1—Disease—SLC11A1—Crohn's disease	1.52e-05	0.000344	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GPX4—Crohn's disease	1.49e-05	0.000338	CbGpPWpGaD
Lamivudine—NME1—Metabolism—ALB—Crohn's disease	1.47e-05	0.000333	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	1.46e-05	0.000331	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GCKR—Crohn's disease	1.44e-05	0.000326	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—TNF—Crohn's disease	1.4e-05	0.000318	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—FADS1—Crohn's disease	1.4e-05	0.000317	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—FADS1—Crohn's disease	1.39e-05	0.000314	CbGpPWpGaD
Lamivudine—SLC22A3—Transmembrane transport of small molecules—ALB—Crohn's disease	1.36e-05	0.000308	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—ALB—Crohn's disease	1.36e-05	0.000307	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.31e-05	0.000297	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GPX4—Crohn's disease	1.31e-05	0.000297	CbGpPWpGaD
Lamivudine—ABCC1—Disease—RBX1—Crohn's disease	1.3e-05	0.000295	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HSPA1B—Crohn's disease	1.3e-05	0.000295	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GPX4—Crohn's disease	1.3e-05	0.000294	CbGpPWpGaD
Lamivudine—PGK1—Disease—IL6—Crohn's disease	1.3e-05	0.000294	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	1.29e-05	0.000293	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—FADS1—Crohn's disease	1.29e-05	0.000293	CbGpPWpGaD
Lamivudine—NME1—Metabolism—PTGS2—Crohn's disease	1.29e-05	0.000291	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GCKR—Crohn's disease	1.27e-05	0.000287	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—JAK2—Crohn's disease	1.26e-05	0.000286	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GCKR—Crohn's disease	1.25e-05	0.000284	CbGpPWpGaD
Lamivudine—ABCC3—Transmembrane transport of small molecules—ALB—Crohn's disease	1.25e-05	0.000283	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GPX4—Crohn's disease	1.21e-05	0.000274	CbGpPWpGaD
Lamivudine—ABCC4—Transmembrane transport of small molecules—ALB—Crohn's disease	1.17e-05	0.000266	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GCKR—Crohn's disease	1.17e-05	0.000265	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.15e-05	0.00026	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PLA2G4F—Crohn's disease	1.14e-05	0.000259	CbGpPWpGaD
Lamivudine—ABCC1—Disease—UBE2D1—Crohn's disease	1.14e-05	0.000259	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.03e-05	0.000233	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	1.03e-05	0.000232	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—ALB—Crohn's disease	1.02e-05	0.000231	CbGpPWpGaD
Lamivudine—DCK—Metabolism—ALB—Crohn's disease	1.01e-05	0.000228	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—ALB—Crohn's disease	9.9e-06	0.000224	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—ALB—Crohn's disease	9.79e-06	0.000222	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—MTMR3—Crohn's disease	9.72e-06	0.00022	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	9e-06	0.000204	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PTGS2—Crohn's disease	8.82e-06	0.0002	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—ALB—Crohn's disease	8.61e-06	0.000195	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—ALB—Crohn's disease	8.52e-06	0.000193	CbGpPWpGaD
Lamivudine—ABCC1—Disease—SMAD3—Crohn's disease	8.17e-06	0.000185	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—ALB—Crohn's disease	7.94e-06	0.00018	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—FADS1—Crohn's disease	7.58e-06	0.000172	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GPX4—Crohn's disease	7.09e-06	0.000161	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	6.92e-06	0.000157	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GCKR—Crohn's disease	6.85e-06	0.000155	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—ALB—Crohn's disease	6.36e-06	0.000144	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—ALB—Crohn's disease	5.85e-06	0.000132	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PTGS2—Crohn's disease	5.57e-06	0.000126	CbGpPWpGaD
Lamivudine—ABCC1—Disease—TYK2—Crohn's disease	5.33e-06	0.000121	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PTGS2—Crohn's disease	5.12e-06	0.000116	CbGpPWpGaD
Lamivudine—ABCC1—Disease—JAK2—Crohn's disease	5.09e-06	0.000115	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CD4—Crohn's disease	4.82e-06	0.000109	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PTGS2—Crohn's disease	4.79e-06	0.000108	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	4.66e-06	0.000105	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ALB—Crohn's disease	4.58e-06	0.000104	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ALB—Crohn's disease	4.03e-06	9.13e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PTGS2—Crohn's disease	4.01e-06	9.08e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ALB—Crohn's disease	3.99e-06	9.04e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—STAT3—Crohn's disease	3.73e-06	8.46e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ALB—Crohn's disease	3.72e-06	8.42e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PTGS2—Crohn's disease	3.53e-06	7.99e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PTGS2—Crohn's disease	3.49e-06	7.91e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PTGS2—Crohn's disease	3.25e-06	7.37e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—IL6—Crohn's disease	2.61e-06	5.91e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ALB—Crohn's disease	2.18e-06	4.94e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PTGS2—Crohn's disease	1.91e-06	4.32e-05	CbGpPWpGaD
